FindTrial
Sign In

RNA based biomarkers in breast cancer patients

To investigate the clinical diagnostic potential of dysregulated microRNAs as early biomarkers in breast cancer patients - NIL

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
CTRI
Registry ID
CTRI/2025/02/081106
Enrollment
15
Registered
2025-02-21
Start date
Unknown
Completion date
Unknown
Last updated
2025-03-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: C509- Malignant neoplasm of breast of unspecified site

Interventions

Intervention1: NIL: NIL

Sponsors

PRAMOD KUMAR AVTI
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1. Female breast cancer patients. 2. Breast cancer patient age between 20-80 years. 3. Patient diagnosed through mammographic techniques. 4. All stages of diseases. 5. Surgery or mastectomy patients will be included. 6. With or without treatment patients will be included in this study.

Exclusion criteria

Exclusion criteria:

Design outcomes

Primary

MeasureTime frame
Post surgical breast tumor tissue/blood will be collected for miRNAs expression, tumor suppressor genes, DNA repair genes and breast cancer receptor marker expression.Timepoint: The samples will be processed and analyzed at 12 months—

Secondary

MeasureTime frame
NILTimepoint: NIL—

Countries

India

Contacts

Public ContactDR DIVYA DAHIYA

POSTGRADUATE INSTITUTE OF MEDICAL EDUCATION AND RESEARCH

pramod.avti@gmail.com9876955337

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026